ILC Research Publication Library

The Lobular Breast Cancer Alliance has compiled a reference list of ILC research and studies related to lobular breast cancer.  The list includes studies from 2000 to the present.  We will update this research list periodically.  Follow @LobularBCA and #lobular on Twitter to access up-to-date research.

How to use this table: Use the headers on the columns to sort by category.   Use the Search function to locate specific study topics.   To read a full article with restricted access consult a local medical library or purchase access to the full article (LBCA can not send or link to restricted articles due to license limitations). Suggestions for additions or changes to this list can be emailed to info@lobularbreastcancer.org for review.  Updated October, 2019

Publications and Articles

NOTE:  Scroll left within the table for links to the full study or abstract.

AUTHORTITLEPUBLICATIONDATEType of ArticleGeneral SubjectSpecific SubjectLinkDate Added
AbreuInvasive lobular carcinoma: a rare presentation in the male breastBMJ Case report2016Case ReportClinicopathologicalILC in Male patientshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885473/11/1/2019
AdachiComparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinomaBMC Cancer2016RetrospectiveClinicopathologicalPrognosishttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807554/5/1/2019
AnCdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the BreastCell Reports2018Laboratory ResearchGenomicsLab Modelshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276789/5/1/2019
AnwarInvasive lobular carcinoma of the breast: Should this be regarded as a chronic disease?Intl J Surg2010RetrospectiveClinicopathologicalPrognosishttps://www.sciencedirect.com/science/article/pii/S174391911000065811/1/2019
ArpinoInfiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcomeBreast Cancer Research2004RetrospectiveClinicopathologicalPrognosishttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC400666/5/1/2019
ArthurMolecular Changes in Lobular Breast Cancers in Response to Endocrine TherapyCancer Res2014RetrospectiveGenomicsAnti-estrogen Therapyhttp://cancerres.aacrjournals.org/content/74/19/5371.long5/1/2019
BaePreoperative MR Imaging in Women with Breast Cancer Detected at Screening USRadiology2017RetrospectiveImagingMRIhttps://pubs.rsna.org/doi/10.1148/radiol.201616070611/1/2019
BagliaAlcohol Intake and Risk of Breast Cancer by Histologic Subtype and Estrogen Receptor Status Among Women Aged 55 to 74 YearsHormones and Cancer2017RetrospectiveRisk FactorsAlcohol usehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779634/5/1/2019
BajramiE-cadherin/ROS1 inhibitor synthetic lethality in breast cancerCancer Disc2018Laboratory ResearchCancer BiologyE-cadherinhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296442/11/1/2019
Barroso-SousaDifferences between invasive lobular and invasive ductal carcinoma of the breast: results and therapeutic implicationsAdv Med Onc2016ReviewClinicopathologicalTherapy Response and Resistancehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4952020/5/1/2019
BergDiagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancerRadiology2004RetrospectiveImagingImaging Modalitieshttps://www.ncbi.nlm.nih.gov/pubmed/154862145/1/2019
BrunerLoss of E-Cadherin-Dependent Cell–Cell Adhesion and the Development and Progression of CancerCSH Perspectives2018ReviewCancer BiologyE-cadherinhttps://cshperspectives.cshlp.org/content/10/3/a029330.long11/1/2019
BuchananIs Pleomorphic Lobular Carcinoma Really a Distinct Clinical Entity?J Surg Oncol2008RetrospectiveClinicopathologicalPleomorphichttps://www.ncbi.nlm.nih.gov/pubmed/284241305/1/2019
CaoFrequent amplifications of ESR1, ERBB2 and MDM4 in primary invasive lobular breast carcinomaCancer Letter2019Laboratory ResearchCancer biologyGenomicshttps://www.ncbi.nlm.nih.gov/pubmed/31229512/11/1/2019
CarcoforoInfiltrating Lobular Carcinoma of the Breast Presenting as Gastrointestinal Obstruction: A Mini ReviewJournal of Cancer2012Case ReportMetastasisGI Metastasishttp://www.jcancer.org/v03p0328.htm5/1/2019
ChenInvasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinomaPLOS One2017RetrospectiveClinicopathologicalPrognosishttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.01823975/1/2019
Chen21-gene recurrence score and adjuvant chemotherapy decisions in patients with invasive lobular breast cancerBiomarkers in Medicine2018RetrospectiveGenomicsOncotype DX and Chemotherapyhttps://www.ncbi.nlm.nih.gov/pubmed/305654725/1/2019
ChristgenLobular breast cancer: molecular basis, mouse and cellular modelsBreast Cancer Research2015ReviewCancer biologyLab Modelshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320436/5/1/2019
ChristgenLobular breast cancer: Clinical, molecular and morphological characteristicsPathology2016ReviewCancer biologyPathologyhttps://www.ncbi.nlm.nih.gov/pubmed/272339405/1/2019
ChristgenOncogenic PIK3CA Mutations in Lobular Breast Cancer ProgressionGenes Chromosones Cancer2013RetrospectiveGenomicsPIK3CA Mutationshttps://www.ncbi.nlm.nih.gov/pubmed/229970915/1/2019
ChristofanilliInvasive Lobular Carcinoma Classic Type: Response to Primary Chemotherapy and Survival OutcomesJournal of Clinical Oncology2005RetrospectiveClinicopathologicalChemotherapyhttps://ascopubs.org/doi/full/10.1200/JCO.2005.03.1115/1/2019
CirielloComprehensive Molecular Portraits of Invasive Lobular Breast CancerCell2015Laboratory ResearchGenomicsGenetic basis of ILChttps://doi.org/10.1016/j.cell.2015.09.0335/1/2019
ConlonIs There a Role for Oncotype Dx Testing in Invasive Lobular CarcinomaBreast Journal2015RetrospectiveGenomicsOncotype DXhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995885/5/1/2019
CorsoCDH1 germline mutations and hereditary lobular breast cancer.Fam Cancer2016ReviewHereditary breast cancerHereditary CDH1 mutationhttps://www.ncbi.nlm.nih.gov/pubmed/26759166/5/1/2019
CostarelliPleomorphic lobular carcinoma: is it more similar to a classic lobular cancer or to a high-grade ductal cancer?Breast Cancer2017RetrospectiveCancer biologyPleomorphic ILChttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726360/5/1/2019
DashevskyAppearance of untreated bone metastases from breast cancer on FDG PET/CT: Importance of histologic subtypeEur J Nucl Med Mol Imaging2015RetrospectiveImagingImaging-Bone Metastaseshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558334/5/1/2019
de GrootαE‐catenin is a candidate tumor suppressor for the development of E‐cadherin‐expressing lobular‐type breast cancerJ Pathology2018Laboratory ResearchCancer BiologyE-cadherinhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055824/11/1/2019
DelpechClinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomasBritish Journal of Cancer2013RetrospectiveClinicopathologicalChemotherapyhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566807/5/1/2019
DeniziatERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomasOncotarget2016RetrospectiveGenomicsHER2https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341983/5/1/2019
DerksenMammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in miceDis Model Mech2011Laboratory ResearchCancer BiologyLab models of ILChttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097456/11/1/2019
DerksenSomatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesisCancer Cell2006Laboratory ResearchCancer BiologyMetastasis /Lab models of ILChttps://www.cell.com/cancer-cell/fulltext/S1535-6108(06)00288-111/1/2019
DesmedtGenomic Characterization of Primary Invasive Lobular Breast CancerJournal of Clinical Oncology2016Laboratory ResearchGenomicsGenetic basis of ILChttps://ascopubs.org/doi/full/10.1200/JCO.2015.64.03345/1/2019
DesmedtESR1 mutations in metastatic lobular breast cancer patientsnpj Breast Cancer2019RetrospectiveGenomicsEstrogen receptor mutationhttps://www.nature.com/articles/s41523-019-0104-z5/1/2019
DesmedtImmune Infiltration in Invasive Lobular Breast CancerJ Natl Cancer Inst.2018RetrospectiveCancer biologyImmunologyhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037125/5/1/2019
DiPiroLobular breast cancer: patterns of intraabdominal metastatic spread on imaging and prognosticsignificance.Abdom Radiology2019RetrospectiveClinicopathologicalAbdominal Metastasishttps://www.ncbi.nlm.nih.gov/pubmed/3007643011/1/2019
DitchiLow risk of invasive lobular carcinoma of the breast in carriers of BRCA1 and TP53 (Li-Fraumeni syndrome) germline mutationsBreast Journal2018RetrospectiveHereditary breast cancerHereditary BRCA1/2 and p53 mutationhttps://onlinelibrary.wiley.com/doi/full/10.1111/tbj.131545/1/2019
DixonInvasive lobular carcinoma: response to neoadjuvant letrozole therapyBreast Cancer Res Treat2011RetrospectiveClinicopathologicalAnti-estrogen Therapyhttps://www.ncbi.nlm.nih.gov/pubmed/218701295/1/2019
DossusLobular breast cancer: incidence and genetic and non-genetic risk factorsBreast Cancer Research2015ReviewGenomicsRisk and incidencehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357148/5/1/2019
DuKey regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancerBreast Cancer Research2018Laboratory ResearchCancer biologyAnti-estrogen resistancehttps://doi.org/10.1186/s13058-018-1041-85/1/2019
EngstromInvasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypesHistopathology2015RetrospectiveClinicopathologicalPrognosishttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329418/5/1/2019
GainerInvasive Lobular Carcinoma Predicts Micrometastasis in Breast CancerJournal or Surgical Research2012Laboratory ResearchCancer biologyMetastasishttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419792/5/1/2019
GatzaAnother Breast Cancer Entity Confirmed: Genomics of Invasive Lobular Breast CancerJournal of Clinical Oncology2016ReviewGenomicsGenomics of ILChttp://ascopubs.org/doi/10.1200/JCO.2015.66.38725/1/2019
GuiuInvasive lobular breast cancer and its variants: how special are they for systemic therapy decisions?Crit Rev Onco Hematology2014ReviewClinicopathologicalTherapy Response and Resistancehttps://www.ncbi.nlm.nih.gov/pubmed/25129506/5/1/2019
GuvenSentinel Lymph Node Metastasis in Invasive Lobular Carcinoma of the BreastEuropean Journal Br Helath2018RetrospectiveMetastasisLymph node Metastasishttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5939975/5/1/2019
HaBreast MR Imaging before Surgery: Outcomes in Patients with Invasive Lobular Carcinoma by Using Propensity Score MatchingRadiology2018RetrospectiveImagingMRIhttps://pubs.rsna.org/doi/10.1148/radiol.20181714725/1/2019
HeDistant Metastatic Disease Manifestations in Infiltrating Lobular Carcinoma of the BreastAJR2014ReviewMetastasisMetastatic Siteshttps://www.ajronline.org/doi/full/10.2214/AJR.13.111565/1/2019
HoganComparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal CarcinomaJ Nucl Med2015RetrospectiveImagingFDG PET/CThttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869690/11/1/2019
HornsveldRestraining FOXO3-dependent transcriptional BMF activation underpins tumour growth and metastasis of E-cadherin-negative breast cancerCell Death Diff2016Laboratory ResearchCancer BiologyMetastasis /E-cadherinhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072425/11/1/2019
InoueSpecific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancerBreast Cancer2017RetrospectiveMetastasisMetastatic Siteshttps://www.ncbi.nlm.nih.gov/pubmed/281089675/1/2019
IorfidaInvasive lobular breast cancer: subtypes and outcomeBreast Cancer Res Treat2012RetrospectiveClinicopathologicalPrognosishttps://www.ncbi.nlm.nih.gov/pubmed/22399188/11/1/2019
IshidaPleomorphic lobular carcinoma in a male breast: a case report with review of the literatureInt J Clin Exp Pathol2013Case ReportClinicopathologicalILC in Male patientshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693213/11/1/2019
JacobsIssues Affecting the Loco-regional and Systemic Management of Patients with Invasive Lobular Carcinoma of the BreastThe Breast Journal2015ReviewClinicopathologicalTherapy Response and Resistancehttps://www.ncbi.nlm.nih.gov/pubmed/267829515/1/2019
JohnsonLobular breast cancer series: imagingBreast Cancer Research2015ReviewImagingImaging Modalitieshttps://doi.org/10.1186/s13058-015-0605-05/1/2019
KatzPrimary systemic chemotherapy of invasive lobular carcinoma of the breastLancet2007ReviewClinicopathologicalChemotherapyhttps://www.ncbi.nlm.nih.gov/pubmed/171965115/1/2019
KorhonenThe impact of lobular and ductal breast cancer histology on the metastatic behavior and long term survival of breast cancer patientsThe Breast2013RetrospectiveClinicopathologicalMetastasishttps://www.thebreastonline.com/article/S0960-9776(13)00130-6/fulltext11/1/2019
KutasovicBreast cancer metastasis to gynaecological organs: a clinico‐pathological and molecular profiling studyJ Pathol Clin Res2019RetrospectiveGenomicsGynocological Metastasishttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317061/11/1/2019
LanglandsContralateral breast cancer: incidence according to ductal or lobular phenotype of the primaryClinical Radiology2016RetrospectiveClinicopathologicalContralateral Breast Cancerhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726360/5/1/2019
LevineFGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtypeNPJ Breast Cancer2019Laboratory ResearchMetastasisGenomicshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597581/11/1/2019
LiHormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women.Cancer2000RetrospectiveRisk FactorsHormone Replacement Therapyhttps://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142%2820000601%2988%3A11%3C2570%3A%3AAID-CNCR20%3E3.0.CO%3B2-O5/1/2019
LiChanging Incidence Rate of Invasive Lobular Breast Carcinoma among Older WomenCancer2000RetrospectiveRisk FactorsIncidencehttps://www.ncbi.nlm.nih.gov/pubmed/108614345/1/2019
LiaoThe Clinicopathological Features and Survival Outcomes of Different Histological Subtypes in Triple-negative Breast CancerJ Cancer2018RetrospectiveClinicopathologicalTriple-negative ILChttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771337/5/1/2019
LoganMolecular drivers of lobular carcinoma in situBreast Cancer Research2015ReviewCancer biologyLCIShttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453073/5/1/2019
LokadasanMetastatic lobular carcinoma of breast mimics primary cervix carcinoma: two case reports and a review of the literatureecancermedicalscience2015Case ReportMetastasisCervical Metastasishttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583243/5/1/2019
LopezInvasive Lobular Carcinoma of the Breast: Spectrum of Mammo- graphic, US, and MR Imaging FindingsRadiographics2009ReviewImagingImaging modalitieshttps://pubs.rsna.org/doi/10.1148/rg.2910851005/1/2019
MamtaniLobular Breast Cancer Different Disease, Different AlgorithmsSurgical Oncol Cinics2018ReviewGenomicsGenomics of ILChttps://www.ncbi.nlm.nih.gov/pubmed/291325675/1/2019
MannMRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breastBreast Cancer Res Treat2008ReviewImagingMRIhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2096637/11/1/2019
MarmorRelative Effectiveness of Adjuvant Chemotherapy for Invasive Lobular Compared With Invasive Ductal Carcinoma of the BreastCancer2017RetrospectiveClinicopathologicalChemotherapyhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.3069911/1/2019
MathewDistinct Pattern of Metastases in Patients with Invasive Lobular Carcinoma of the BreastGeburtshilfe Frauenheilkd2017RetrospectiveMetastasisMetastatic siteshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489406/5/1/2019
MathieuThe poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profileEur J Cancer2004RetrospectiveClinicopathologicalChemotherapyhttps://www.ncbi.nlm.nih.gov/pubmed/147468515/1/2019
McLemoreBreast cancer: presentation and intervention in women with gastrointestinal metastasis and carcinomatosisAnn Surg Onc2005RetrospectiveMetastasisGI Metastasishttps://www.ncbi.nlm.nih.gov/pubmed/1617786411/1/2019
Metzger-FilhoGenomic grade adds prognostic value in invasive lobular carcinomaAnn Onc2013RetrospectiveGenomicsGene Signatureshttps://academic.oup.com/annonc/article/24/2/377/22304611/1/2019
Metzger-FilhoMixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic GradeThe Oncologist2019RetrospectiveClinicopathologicalMixed ILC/IDChttp://theoncologist.alphamedpress.org/content/24/7/e441.long11/1/2019
Metzger-FilhoMagnitude of trastuzumab benefit in patients with HER2-positive, invasive lobular breastcarcinoma: results from the HERA trialJournal of Clinical Oncology2013RetrospectiveClinicopathologicalHER2-targeted therapyhttps://ascopubs.org/doi/10.1200/JCO.2012.46.24405/1/2019
Metzger-FilhoRelative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 TrialJournal of Clinical Oncology2015RetrospectiveClinicopathologicalAnti-estrogen therapyhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550691/5/1/2019
MichautIntegration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancerSci Rep2016Laboratory ResearchGenomicsGenetic basis of ILChttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700448/11/1/2019
MontagnaLobular Metastatic Breast Cancer Patients With Gastrointestinal Involvement: Features and OutcomesClinical Breast Cancer2018RetrospectiveMetastasisMetastatic siteshttps://www.ncbi.nlm.nih.gov/pubmed/28778379/5/1/2019
MotenCharacterizing lobular carcinoma of the male breast using the SEER database.J surg Res2013RetrospectiveClinicopathologicalILC in Male patientshttps://www.ncbi.nlm.nih.gov/pubmed/240710245/1/2019
MukhtarBreast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 PatientsAnnals of Surgical Oncol2018RetrospectiveClinicopathologicalSurgical methodshttps://www.ncbi.nlm.nih.gov/pubmed/300548265/1/2019
NagleLoss of E-cadherin Enhances IGF1–IGF1R Pathway Activation and Sensitizes Breast Cancers to Anti-IGF1R/InsR InhibitorsClinical Cancer Research2018Laboratory ResearchCancer biologyCell signalinghttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821389/5/1/2019
OesterreichOpening the Door for Immune Oncology Studies in Invasive Lobular Breast CancerJ Natl Cancer Inst.2018ReviewCancer biologyImmunologyhttps://academic.oup.com/jnci/article/110/7/696/48817625/1/2019
OliveraEvolving concepts in breast lobular neoplasia and invasive lobular carcinoma, and their impact on imaging methodsInsights Imaging2014ReviewImagingImaging modalitieshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999371/5/1/2019
OrvietoClinicopathologic characteristics of invasive lobular carcinoma of the breastCancer2008RetrospectiveClinicopathologicalPrognosishttps://onlinelibrary.wiley.com/doi/full/10.1002/cncr.238115/1/2019
PatelValue Added of Preoperative Contrast-Enhanced Digital Mammography in Patients With Invasive Lobular Carcinoma of the BreastClinical Breast Cancer2018RetrospectiveImagingMammography methodshttps://www.ncbi.nlm.nih.gov/pubmed/301223475/1/2019
Perez-GarciaEfficacy of Single-Agent Chemotherapy for Patients with Advanced Invasive LobularCarcinomaThe Oncologist2018RetrospectiveClinicopathologicalChemotherapyhttps://www.ncbi.nlm.nih.gov/pubmed/305783115/1/2019
PestalozziDistinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International clinical trialsJ Clin Oncol2008RetrospectiveClinicopathologicalPrognosishttps://ascopubs.org/doi/full/10.1200/JCO.2007.14.93365/1/2019
PetridisFrequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic Lobular Breast CancerCancer Epidemiol Biomark2019RetrospectiveGenomicsGenetic basis of ILChttps://www.ncbi.nlm.nih.gov/pubmed/31263054/11/1/2019
PhalakSupplemental ultrasound screening in patients with a history of lobular neoplasiaThe Breast Journal2018RetrospectiveImagingImaging modalitieshttps://www.ncbi.nlm.nih.gov/pubmed/306759295/1/2019
RaapLobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2β.Lab Invest2017Laboratory ResearchCancer BiologyGenomics of ILChttps://www.ncbi.nlm.nih.gov/pubmed/2903537911/1/2019
RaapHigh frequency of lobular breast cancer in distant metastases to the orbitCancer Med2015RetrospectiveMetastasisOribital Metastasishttps://www.nature.com/articles/labinvest20171065/1/2019
RakhaInvasive lobular carcinoma of the breast: response to hormonal therapy and outcomesEur J Cancer2008RetrospectiveClinicopathologicalAnti-estrogen therapyhttps://www.ncbi.nlm.nih.gov/pubmed/18035533/5/1/2019
ReedLobSig is a multigene predictor of outcome in invasive lobular carcinomaNPJ Breast Cancer2019Laboratory ResearchGenomicsGene signatureshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597578/11/1/2019
ReedInvasive lobular carcinoma of the breast: morphology, biomarkers and ’omicsBreast Cancer Research2015ReviewCancer biologyGenomics of ILChttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310190/5/1/2019
ReedMixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphologyJ Pathology2018RetrospectiveCancer biologyMixed ductal-lobularhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873281/5/1/2019
RigginsERRγ mediates Tamoxifen resistance in novel models of invasive lobular breast cancerCancer Res2008Laboratory ResearchCancer biologyAnti-estrogen resistancehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701641/11/1/2019
Rosa-RosaHigh Frequency of ERBB2 Activating Mutations in Invasive Lobular Breast Carcinoma with Pleomorphic FeaturesCancers2019RetrospectiveCancer biologyHER2 mutation in PLChttps://www.mdpi.com/2072-6694/11/1/74/htm5/1/2019
RossRelapsed Classic E-Cadherin (CDH1)–Mutated Invasive Lobular Breast Cancer Shows a High Frequency of HER2 (ERBB2) Gene MutationsClinical Cancer Research2013RetrospectiveGenomicsHER2 mutation in ILChttp://clincancerres.aacrjournals.org/content/19/10/2668.long5/1/2019
SawyerGenetic Predisposition to In Situ and Invasive Lobular Carcinoma of the BreastPLOS2014RetrospectiveGenomicsGenetic Basis of ILC/LCIShttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990493/5/1/2019
SchackmannCytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistanceJ Clin Invest2011Laboratory ResearchCancer BiologyCell Signalinghttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148719/11/1/2019
SelinkoRole of sonography in diagnosing and staging invasive lobular carcinomaJ Clin Ultrasound2004RetrospectiveImagingImaging Methodshttps://www.ncbi.nlm.nih.gov/pubmed/152932985/1/2019
SengerInvasive lobular carcinoma of the male breast – a systematic review with an illustrative case studyBreast Cancer2017Case ReportClinicopathologicalILC in male patientshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439541/5/1/2019
ShahPIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progressionBreast Cancer Research2017RetrospectiveGenomicsPIK3CA mutations in LCIShttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240238/5/1/2019
SikoraInvasive lobular carcinoma of the breast: Patient response to systemic endocrine therapy and hormone response in model systemsSteroids2012ReviewCancer biologyAnti-estrogen therapyhttps://www.ncbi.nlm.nih.gov/pubmed/231781595/1/2019
SikoraInvasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen responseCancer Resarch2014Laboratory ResearchCancer biologyAnti-estrogen response and resistancehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955299/5/1/2019
SikoraWNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell linesBreast Cancer Research2016Laboratory ResearchCancer biologyAnti-estrogen response and resistancehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028957/5/1/2019
SingletaryTreatment Trends in Early-Stage Invasive Lobular CarcinomaAnn Surgery2005RetrospectiveClinicopathologicalSurgical Methodshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1357735/5/1/2019
SledgeCollective Wisdom: Lobular Carcinoma of the BreastASCO2016ReviewCancer biologyTherapy response and resistancehttps://meetinglibrary.asco.org/record/154110/edbook5/1/2019
SokolLoss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancerAnn Oncol2018Laboratory ResearchGenomicsAnti-estrogen resistancehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336006/5/1/2019
StangeHigh-Resolution Genomic Profiling Reveals Association of Chromosomal Aberrations on 1q and 16p with Histologic and Genetic Subgroups of IBC cell linesClinical Cancer Research2006RetrospectiveGenomicsGenomics of ILChttp://clincancerres.aacrjournals.org/content/12/2/345.long5/1/2019
Strasser-WeipplOutcomes in women with invasive ductal or invasive lobular early stage breast cancer treated with anastrozole or exemestaneEuropean Journal of Cancer2018RetrospectiveClinicopathologicalAnti-estrogen therapyhttps://www.ncbi.nlm.nih.gov/pubmed/292746175/1/2019
SwitzerCase series of 21 patients with extrahepatic metastatic lobular breast carcinoma to the gastrointestinal tractCancer Treat Comm2015Case ReportMetastasisGI Metastasishttps://www.sciencedirect.com/science/article/pii/S221308961400014011/1/2019
TalmanInvasive lobular breast cancer. Prognostic significance of histological malignancy gradingActa Onc2006RetrospectiveClinicopathologicalPrognosishttps://www.tandfonline.com/doi/full/10.1080/0284186060113739711/1/2019
TamarisaThe impact of chemotherapy sequence on survival in node-positive invasive lobular carcinomaJ Surg Onco2019RetrospectiveClinicopathologicalChemotherapyhttps://www.ncbi.nlm.nih.gov/pubmed/31062375/11/1/2019
TasdemirComprehensive phenotypic characterization of human invasive lobular carcinoma cell lines in 2D and 3D culturesCancer Resarch2018Laboratory ResearchCancer biologyLab modelshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507416/5/1/2019
Tenhagenp120-Catenin Is Critical for the Development of Invasive Lobular Carcinoma in MiceJ Mamm Gland Biol Neo2016Laboratory ResearchCancer BiologyLab models of ILChttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159444/11/1/2019
TeoE-cadherin loss induces targetable autocrine activation of growth factor signalling in lobular breast cancerScientific Reports2018Laboratory ResearchCancer biologyCell signalinghttps://www.nature.com/articles/s41598-018-33525-55/1/2019
ThomasInvasive lobular breast cancer: A review of pathogenesis, diagnosis, management, and future directions of early stage diseaseSemin Oncol2019ReviewClinicopathologicalNeoadjuvant Therapyhttps://www.ncbi.nlm.nih.gov/pubmed/3123906811/1/2019
TruinDifferences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast CancerAnnals of Surgical Oncol2016RetrospectiveClinicopathologicalChemotherapyhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695495/5/1/2019
UlanerProspective Clinical Trial of 18F-Fluciclovine PET/CT for Determining the Response to Neoadjuvant Therapy in IDC and ILCJournal of Nuclear Medicine2017RetrospectiveImaging18 F-Fluciclovine PET/CThttp://jnm.snmjournals.org/content/58/7/1037.long5/1/2019
van de VenNuclear p120-catenin regulates the anoikis resistance of mouse lobular breast cancer cells through Kaiso-dependent Wnt11 expressionDis Model Mech2015Laboratory ResearchCancer BiologyCell Signalinghttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381336/11/1/2019
van de WaterInfluence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancerEur J Cancer2012RetrospectiveClinicopathologicalAnti-estrogen Therapyhttps://www.ejcancer.com/article/S0959-8049(12)00609-0/fulltext5/1/2019
VargasPleomorphic lobular carcinoma of the breast: molecular pathology and clinical impactFuture Oncol2009ReviewGenomicsPleomorphichttps://www.ncbi.nlm.nih.gov/pubmed/192843815/1/2019
Venema18F-FES PET Has Added Value in Staging and Therapy Decision Making in Patients With Disseminated Lobular Breast Cancer.Clin Nucl Med2017Laboratory ResearchImagingFES PEThttps://www.ncbi.nlm.nih.gov/pubmed/28604479/5/1/2019
VlugNuclear localization of the transcriptional coactivator YAP is associated with invasive lobular breast cancerCell Oncol2013Laboratory ResearchCancer BiologyCell Signalinghttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777165/11/1/2019
WangThe Distribution and Outcomes of the 21-Gene Recurrence Score in T1-T2N0 Estrogen Receptor-Positive Breast Cancer With Different Histologic SubtypesFrontiers in Genetics2018RetrospectiveGenomicsOncotype DXhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304349/5/1/2019
WinstonMetastatic Lobular Carcinoma of the Breast: Patterns of Spread in the Chest, Abdomen, and Pelvis on CTAJR2000RetrospectiveMetastasisMetastatic siteshttps://www.ajronline.org/doi/full/10.2214/ajr.175.3.17507955/1/2019
XiaoMixed invasive ductal and lobular carcinoma has distinct clinical features and predicts worse prognosis when stratified by estrogen receptor statusScientific reports2017RetrospectiveClinicopathologicalMixed IDC/ILChttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583173/5/1/2019
XicolaClinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteriaJ Med Genet2019RetrospectiveClinicopathologicalGenitic basis of ILChttps://jmg.bmj.com/content/56/12/838.long11/1/2019
XinA review of invasive lobular carcinoma of the breast: Should it be treated like invasive ductal carcinoma?Integr Cancer Sci Therapy2007ReviewClinicopathologicalPrognosishttps://www.oatext.com/pdf/ICST-3-211.pdf5/1/2019
YuClassical-type invasive lobular carcinoma with HER2 overexpression: clinical, histologic, and hormone receptor characteristicsAm J Clinical Path2011Case ReportCancer biologyHER2 in ILChttps://academic.oup.com/ajcp/article/136/1/88/17664315/1/2019